Important Notice to Long-Term Shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR)

Retrieved on: 2025-07-21 14:37:03

Tags for this article:

Intercontinental Exchange

Economy of New York City

NASDAQ

Securities fraud

New York Stock Exchange

Centene Corporation

Securities Class Action

Joshua H. Grabar

Capricor Therapeutics Inc.

Joshua Grabar

Click the tags to see associated articles and topics

Important Notice to Long-Term Shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). View article details on hiswai:

Excerpt

(NASDAQ: CAPR); Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law ...

Article found on: www.globenewswire.com

View Original Article